Rationale to evaluate medically supervised safer smoking facilities for non-injection illicit drug users
- PMID: 16238151
- PMCID: PMC6975595
- DOI: 10.1007/BF03404029
Rationale to evaluate medically supervised safer smoking facilities for non-injection illicit drug users
Abstract
Many cities are experiencing ongoing infectious disease epidemics and substantial community harm as a result of illicit drug use. In an effort to reduce these public order and public health concerns, consideration has been given to the opening in Vancouver of a safer smoking facility (SSF). The present review was conducted to examine if there is a rationale to support the evaluation of a SSF in the Canadian context. Available evidence suggests that conventional drug control strategies are insufficient to address the health and community harms of non-injection drug use, and that the public order benefits of supervised injection facilities may be relevant to SSFs. In addition, there is persuasive evidence to suggest there is potential for blood-borne disease transmission through the sharing of smoking paraphernalia, and the potential for SSFs to address this concern is a pressing public health question. Also relevant to this topic are interventions to prevent transition into injection drug use, and SSFs may also be evaluated as a potential strategy to address this concern.
Plusieurs villes doivent composer avec des épidémies continues de maladies infectieuses et les dommages importants causés par l’utilisation de drogues illicites. Afin de réduire le nombre d’infractions à l’ordre public et d’apaiser les préoccupations en matière de santé publique, on a envisagé la création, à Vancouver, d’installations sécuritaires pour les fumeurs de drogues illicites (ISFDI). La présente évaluation avait pour but d’examiner s’il s’avérait justifié d’appuyer l’évaluation d’une ISFDI dans le contexte canadien. Les preuves disponibles révèlent que, d’une part, les stratégies antidrogues habituelles ne suffisent pas à contrer les effets sur la santé et la collectivité de l’utilisation des drogues non injectables et que, d’autre part, les effets positifs de la création de sites d’injection sur le maintien de l’ordre public peut justifier la création d’ISFDI. De plus, certaines données probantes convaincantes laissent supposer qu’il pourrait y avoir des répercussions positives sur la transmission de maladies à diffusion hématogène qui découlent du partage des articles des fumeurs et la possibilité que les ISFDI puissent remédier à cette situation constitue une question de santé publique prioritaire. Les interventions visant à prévenir le passage aux drogues à injection représentent un autre sujet pertinent à l’étude de la présente question; on pourrait également évaluer les ISFDI comme un moyen stratégique éventuel pour corriger cette situation.
Similar articles
-
Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.J Urban Health. 2005 Jun;82(2):276-84. doi: 10.1093/jurban/jti051. Epub 2005 May 4. J Urban Health. 2005. PMID: 15872188 Free PMC article.
-
Peer-engagement and its role in reducing the risky behavior among crack and methamphetamine smokers of the Downtown Eastside community of Vancouver, Canada.Harm Reduct J. 2016 Jun 8;13(1):19. doi: 10.1186/s12954-016-0108-z. Harm Reduct J. 2016. PMID: 27278459 Free PMC article.
-
Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder.Subst Abuse Treat Prev Policy. 2011 Feb 23;6:4. doi: 10.1186/1747-597X-6-4. Subst Abuse Treat Prev Policy. 2011. PMID: 21345231 Free PMC article.
-
A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.Drug Alcohol Rev. 2006 Nov;25(6):611-24. doi: 10.1080/09595230600944529. Drug Alcohol Rev. 2006. PMID: 17132577 Review.
-
Impact of supervised injection facilities on community HIV levels: a public health perspective.Expert Rev Anti Infect Ther. 2003 Dec;1(4):543-9. doi: 10.1586/14787210.1.4.543. Expert Rev Anti Infect Ther. 2003. PMID: 15482151 Review.
Cited by
-
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment.Can J Infect Dis Med Microbiol. 2016;2016:4385643. doi: 10.1155/2016/4385643. Epub 2016 Jul 4. Can J Infect Dis Med Microbiol. 2016. PMID: 27471521 Free PMC article.
-
Public opinions about supervised smoking facilities for crack cocaine and other stimulants.Subst Abuse Treat Prev Policy. 2016 Feb 9;11:8. doi: 10.1186/s13011-016-0052-7. Subst Abuse Treat Prev Policy. 2016. PMID: 26860540 Free PMC article.
-
Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users.Harm Reduct J. 2006 Jan 10;3:1. doi: 10.1186/1477-7517-3-1. Harm Reduct J. 2006. PMID: 16403229 Free PMC article.
-
A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada.Harm Reduct J. 2014 Nov 13;11(1):30. doi: 10.1186/1477-7517-11-30. Harm Reduct J. 2014. PMID: 25395278 Free PMC article.
-
Supervised smoking facility access, harm reduction practices, and substance use changes during the COVID-19 pandemic: a community-engaged cross-sectional study.Harm Reduct J. 2023 Jul 31;20(1):101. doi: 10.1186/s12954-023-00825-7. Harm Reduct J. 2023. PMID: 37525168 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical